Diagnostic and Interventional Cardiology

The US Food and Drug Administration is alerting health care providers and facilities about our continued safety and quality concerns with the following Getinge/Maquet cardiovascular medical devices

News | FDA

FDA Notes Safety and Quality Concerns with Getinge/Maquet Cardiovascular Devices

May 8, 2024 — The US Food and Drug Administration (FDA) is alerting health care providers and facilities about our ...

May 08, 2024

News | Peripheral Artery Disease (PAD)

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...

May 08, 2024

News | FDA

4C Medical's AltaValve System Secures Dual FDA Breakthrough Device Designations, Expediting Patient Access to Advanced Mitral Valve Therapies

May 8, 2024 — 4C Medical Technologies, Inc. ("4C Medical"), a medical device company dedicated to advancing minimally ...

May 08, 2024

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Feinstein Institutes’ Dr. Stavros Zanos is the senior author on the new bioelectronic medicine ultrasound paper

News | Hypertension

Ultrasound Neuromodulation Shows Promise to Treat Pulmonary Hypertension, Feinstein Institutes Research

May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine ...

May 08, 2024

AngioFlow by RapidAI will facilitate confident clinical decision-making immediately prior to or after neuro-interventional procedures

News | FDA

RapidAI Secures FDA Clearance for Perfusion Imaging in the Angiography Suite

May 7, 2024 — RapidAI, the global leader in developing clinically deep Artificial Intelligence (AI) and technology ...

May 07, 2024

‘Scattered Denial’ documents how long-term exposure to radiation in catheterization labs may cause cancer

News | Radiation Dose Management

Documentary Led by HonorHealth Research Institute Focuses on Injuries to Doctors and Nurses Working in Cardiology

May 7, 2024 — HonorHealth Research Institute’s David G. Rizik, M.D., narrates and is a co-producer of a documentary ...

May 07, 2024

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Medtronic released clinical outcomes in two transcatheter valve therapies from studies presented at the recent Society for Cardiovascular Angiography & Interventions 2024 Scientific Sessions, SCAI 2024.

News | SCAI

Medtronic TAVR Outcomes from SMART Trial and Optimize PRO Addendum on Evolut TAVR Presented at SCAI 2024 Scientific Sessions

May 7, 2024 — Medtronic announced the release of important clinical outcomes in two leading transcatheter valve ...

May 07, 2024

An example of white matter hyperintensities (WMHs) on a FLAIR MRI scan in an older adult. FLAIR MRI is a technique that is particularly good at detecting fluid in the brain

News | Stroke

New Study Reveals Age-related Brain Changes Influence Recovery After Stroke

May 7, 2024 — A new study by a global team of researchers, led by Sook-Lei Liew, PhD, of USC's Mark and Mary Stevens ...

May 07, 2024

Women and black patients were less frequently treated with minimally invasive therapy compared to men or non-Black patients, according to new data from the REAL-PE analysis which investigated catheter-based pulmonary embolism (PE) treatment. Late-breaking results were presented by lead study author Sahil A. Parikh, MD, Director of Endovascular Services and Professor at Columbia University Irving Medical Center, at the Society for Cardiovascular Angiography & Interventions (SCAI) 2024 Scientific Sessions.

News | SCAI

Women and Black Patients Less Likely to Receive Catheter-based Treatment for Pulmonary Embolism According to REAL-PE Analysis Presented at SCAI 2024

May 7, 2024 — Women and black patients were less frequently treated with minimally invasive therapy compared to men or ...

May 07, 2024

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

HeartX's portfolio includes advanced products like the JOVE VB Stent for Sinus Venous ASD

News | Cardiovascular Business

SMT and HeartX Forge Transformative Partnership in Cardiovascular Space

May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative ...

May 06, 2024

Company expands structural heart portfolio and begins the limited market release of a bipolar temporary pacing guidewire

News | Guidewires

Teleflex Announces the Limited Market Release of the Wattson Temporary Pacing Guidewire

May 6, 2024 — Teleflex Incorporate, a leading global provider of medical technologies, today announced that the Wattson ...

May 06, 2024

Represents the third patent granted to Tenax since March of 2023 protecting the use of levosimendan in the treatment of PH-HFpEF

News | Pharmaceuticals

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

May 6, 2024 — Tenax Therapeutics, Inc., a Phase 3, development-stage pharmaceutical company focused on identifying ...

May 06, 2024

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

A look at DAIC's top-viewed content for April 2024

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

DAIC's Top 10 for April

Clinical trials and innovative technology took center stage during the month of April, racking up some record number ...

May 03, 2024

Reprieve Cardiovascular partners with leading heart failure researchers and Truveta to analyze real-world heart failure patient data to highlight opportunities to improve the current patient management paradigm

News | Cardiovascular Clinical Studies

New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged

May 2, 2024 — Reprieve Cardiovascular, Inc. (‘Reprieve’), a development stage company focused on pioneering an ...

May 02, 2024

The primary endpoint results of the open label roll-in cohort of the CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial

News | Cardiovascular Clinical Studies

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes

May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular ...

May 02, 2024